(6R)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine
|
普拉克索雜質(zhì)E
|
104632-28-2
|
(2R,3R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
|
T9α異構(gòu)體
|
134790-40-2
|
(3R)-3-(Aminomethyl)-5-methylhexanoic acid
|
R-普瑞巴林
|
148553-51-9
|
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide
|
N-[[4-(5-甲基-3-苯基-4-異惡唑基)苯基]磺?;鵠乙酰胺
|
198471-06-6
|
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide
|
帕瑞昔布雜質(zhì)
|
198470-82-5
|
2-(2-butyl-4-hydroxy-6-MethylpyriMidin-5-yl)-N,N-diMethylacetaMide
|
2-(2-丁基-4-羥基-6-甲基嘧啶-5-基)-N,N-二甲基乙酰胺
|
1315478-13-7
|
(R)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine
|
中文名稱 (R)-1-(3-乙氧基-4-甲氧基苯基)-(甲磺?;?乙胺 英文名稱 (R)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMi
|
608142-27-4
|
METHOXY-PHENYL-ACETIC ACID METHYL ESTER
|
阿托品雜質(zhì)25
|
3558-61-0
|
5-methyl-3,4-diphenyl-4,5-dihydroisoxazol-5-ol
|
4,5-二氫-5-甲基-3,4-二苯基-5-異惡唑
|
181696-73-1
|
Deoxybenzoin Oxime
|
二苯乙酮肟
|
26306-06-9
|
LevetiracetaM IMpurity B
|
左乙拉西坦雜質(zhì)B
|
358629-47-7
|
Valdecoxib IMpurity B
|
戊地昔布雜質(zhì)B
|
1373038-60-8
|
3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide
|
3-[4-[4-(氨基磺?;?苯基]-5-甲基-3-異惡唑基]苯磺酰胺
|
1373038-59-5
|
Apixaban Impurity 5, Apixaban impurity E (BMS-591329-01)
|
阿哌沙班雜質(zhì)5
|
2029205-64-7
|
2-(CHLOROMETHYL)IMIDAZO[1,2-A]PYRIMIDINE
|
2-氯甲基咪唑并[1,2-A]嘧啶
|
57892-71-4
|
5-Pyrimidineethanethioamide, 1-([1,1'-biphenyl]-4-ylmethyl)-2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-
|
非馬沙坦雜質(zhì)
|
1985668-75-4
|
3-(2-aminoethyl)thiazolidine-2,4-dione hydrochloride
|
3-(2-氨基乙基)-噻唑烷-2,4-二酮,鹽酸
|
19382-49-1
|
(S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide
|
左乙拉西坦雜質(zhì)相關(guān)物質(zhì)A
|
102767-31-7
|
5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-phenyl-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
|
脫氟阿瑞匹坦
|
170729-76-7
|
Apixaban IMpurity 3 (BMS-778960-01)
|
阿哌沙班雜質(zhì)3
|
1801881-18-4
|
Pregabalin Impurity 19
|
普瑞巴林雜質(zhì)19
|
89015-27-0
|
4-amino-1-((2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrochloride
|
鹽酸吉西他濱異構(gòu)體
|
122111-05-1
|
1-((2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
|
α尿苷
|
153381-14-7
|
1-(4-Chlorophenyl)-4,5,6,7-tetrahydro-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
|
反式消旋-7-羥基普拉克索
|
1246818-51-8
|
(2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid
|
左乙拉西坦中間體
|
102849-49-0
|
(Z)-ethyl 3-(2-(((4-(N'-((2-ethylbutoxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
|
達(dá)比加群酯雜質(zhì)CDBA 510 BS
|
2096992-10-6
|
dihydro-4-phenylfuran-2(3H)-one
|
dihydro-4-phenylfuran-2(3H)-one
|
1008-73-7
|
4-(6-Chloropyrazin-2-yl)morpholine
|
4-(6-氯吡嗪-2-基)嗎啉
|
720693-19-6
|
Valdecoxib Impurity D (Parecoxib Impurity 8)
|
帕瑞昔布雜質(zhì)8
|
181696-35-5
|
METHYL ALPHA-BROMOPHENYLACETATE
|
溴苯乙酸甲酯
|
3042-81-7
|
1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl) ethanone
|
1-(3-乙氧基-4-甲氧基苯基)-2-(甲磺?;?乙酮
|
1450657-28-9
|
Ethyl 2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylate
|
達(dá)比加群酯雜質(zhì)G
|
1408238-36-7
|
Parecoxib Sodium Impurity 14
|
間位帕瑞昔布
|
1709956-89-7
|
Apixaban Impurity 23
|
阿哌沙班雜質(zhì)23
|
1801881-17-3
|
Parecoxib ImpurityO
|
帕瑞昔布雜質(zhì)O
|
198470-91-6
|
VALDECOXIB
|
代他考昔
|
181695-72-7
|
1-(6-ETHYNYL-PYRIDIN-2-YL)-ETHANONE
|
1-(6-乙炔基吡啶-2-基)乙酮
|
874379-35-8
|
Deoxybenzoin Oxime
|
二苯乙酮肟
|
952-06-7
|
1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
|
β尿苷
|
114248-23-6
|
(6S,7S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)-7-benzothiazolol
|
順式消旋-7-羥基普拉克索
|
1001648-71-0
|
N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine
|
去乙基達(dá)比加群酯
|
212321-78-3
|
N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine ethyl ester
|
達(dá)比加群酯雜質(zhì)C
|
1408238-40-3
|
Nα-(2,4-Dinitro-5-fluorophenyl)-L-alaninamide
|
N-A-(2,4-二硝基-5-氟苯基)-L-丙氨酸
|
95713-52-3
|
4,4'-(sulfonylbis(4,1-phenylene))bis(5-methyl-3-phenylisoxazole)
|
帕瑞昔布鈉雜質(zhì)
|
2338845-31-9
|
2,5-Difluoropyridine
|
2,5-二氟吡啶
|
84476-99-3
|
((2R,3R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate
|
T9α異構(gòu)體單水解雜質(zhì)
|
|
3-Isobutylglutarimid
|
3-異丁基戊二酰亞胺
|
916982-10-0
|
N-[(1-Methyl-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-β-alanine ethyl ester
|
達(dá)比加群酯雜質(zhì)H
|
1702936-92-2
|
1-(4-Ethoxyphenyl)-4,5,6,7-tetrahydro-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
|
阿哌沙班雜質(zhì)24
|
1928718-22-2
|
Ethyl (S)-5-Amino-3,4-dihydro-2H-pyrrole-2-carboxylate Hydrochloride
|
甲酸乙酯5 - 亞氨基吡咯烷-2S單 - 羧酸鹽酸鹽
|
110971-82-9
|
ENT-Aprepitant
|
ENT-阿瑞匹坦
|
172822-29-6
|
N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine
|
達(dá)比加群酯雜質(zhì)F
|
1408238-37-8
|
Pregabalin EP Impurity A
|
普瑞巴林EP雜質(zhì)A
|
181289-23-6
|
2(5H)-Furanone,4-phenyl-
|
|
1575-47-9
|
2(5H)-Furanone, 5-hydroxy-4-phenyl-
|
|
78920-11-3
|
(R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
|
(R)-左乙拉西坦
|
103765-01-1
|
Parecoxib Impurity H
|
帕瑞昔布雜質(zhì)H
|
1708094-99-8
|
1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine
|
阿普斯特雜質(zhì)
|
1450657-31-4
|
((2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate
|
T9單水解
|
|
1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanol
|
1-(3-乙氧基-4-甲氧基苯基)-2-(甲基磺?;?乙醇
|
2055542-18-0
|
(S)-2-amino-6-(propylamino)-5,6-dihydrobenzo[d]thiazol-7(4H)-one
|
普拉克素雜質(zhì)BI-II546CL
|
2204518-89-6
|
5-Pyrimidineacetamide, 1-([1,1'-biphenyl]-4-ylmethyl)-2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-
|
|
1985668-79-8
|
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide
|
帕瑞昔布雜質(zhì)G
|
386273-25-2
|
Apixaban Impurity 2
|
阿哌沙班雜質(zhì)2
|
1801881-16-2
|
Hexyl N-[(4-aminophenyl)iminomethyl]carbamate
|
達(dá)比加群酯乙二酸雜質(zhì)I
|
255706-13-9
|
N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine methyl ester
|
達(dá)比加群酯雜質(zhì)J
|
211915-00-3
|
4-(2-chloro-5-nitrobenzyl)morpholine
|
4-(2-氯-5-硝基芐基)嗎啉
|
952490-82-3
|
3-Ethoxy-4-methoxybenzamide
|
3-乙氧基-4-甲氧基苯甲酰胺
|
247569-89-7
|
Parecoxib Impurity 4
|
帕瑞昔布雜質(zhì)4
|
57736-10-4
|
((2R,3R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate
|
α尿苷單水解
|
|
ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate 4-methylbenzenesulfonate
|
達(dá)比加群酯雜質(zhì)
|
1610758-16-1
|
((2R,3R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate
|
β尿苷單水解
|
|